Tenet Healthcare (THC)
(Delayed Data from NYSE)
$127.93 USD
-5.04 (-3.79%)
Updated May 16, 2024 03:59 PM ET
After-Market: $127.92 -0.01 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$127.93 USD
-5.04 (-3.79%)
Updated May 16, 2024 03:59 PM ET
After-Market: $127.92 -0.01 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth F Momentum B VGM
Zacks News
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tenet Healthcare (THC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $102.18, denoting a +1.46% change from the preceding trading day.
Tenet Healthcare (THC) Soars 76% in a Year: What Lies Ahead?
by Zacks Equity Research
Tenet Healthcare (THC) remains well-poised for growth on increased admissions and surgeries in the Hospital segment, acquisitions, debt repayment efforts and solid operating cash flows.
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
by Zacks Equity Research
Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $102.05, indicating a -1.12% shift from the previous trading day.
Community Health Systems (CYH) Up 17.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare (THC) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $100.38, moving +0.42% from the previous trading session.
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $95.56, moving +1.99% from the previous trading session.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.
3 Stocks Worth a Deeper Dive in the Thriving Hospital Industry
by Kaibalya Pravo Dey
Following a careful analysis of the Zacks Medical-Hospital industry, we advise focusing on companies like HCA, UHS and THC.
Tenet Healthcare (THC) to Sell Hospitals to Refine Portfolio
by Zacks Equity Research
Tenet Healthcare (THC) enters an agreement with Adventist Health to divest two of THC's hospitals, and continue to make Conifer's revenue cycle management services available for the divested operations.
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $89.22, signifying a -1.12% move from its prior day's close.
Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%
by Zacks Equity Research
Brookdale Senior's (BKD) Q4 results were hit by inflationary challenges, an increase in facility operating lease expense and higher income tax provision. It expects adjusted EBITDA within $90-$95 million in first-quarter 2024.
Teladoc Health (TDOC) Q4 Loss Narrows on Lower Expenses
by Zacks Equity Research
Teladoc Health's (TDOC) Q4 results were aided by strong contributions from the Integrated Care unit and a decline in restructuring costs. Management targets adjusted EBITDA at a minimum of $425 million in 2025.
Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations
by Zacks Equity Research
Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?
by Zacks Equity Research
Tenet's (THC) fourth-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.
Gear Up for Tenet (THC) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Strength Seen in Tenet (THC): Can Its 7.7% Jump Turn into More Strength?
by Zacks Equity Research
Tenet (THC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.